Ceres Inc (CERE) Social Stream
CEREVEL THERAPEUTICS HOLDINGS INC (CERE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CEREVEL THERAPEUTICS HOLDINGS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-07 | 3 | $39 | $33 | $36.333 | $42.64 | -14.79% |
| 2021-11-10 | 3 | $50 | $37 | $42 | $42.64 | -1.5% |
| 2021-12-22 | 4 | $50 | $39 | $47.25 | $42.64 | 10.81% |
| 2022-03-07 | 5 | $50 | $39 | $47.8 | $42.64 | 12.1% |
| 2022-04-12 | 6 | $50 | $39 | $47.8 | $42.64 | 12.1% |
| 2022-05-10 | 6 | $50 | $39 | $47.5 | $42.64 | 11.4% |
| 2022-05-11 | 6 | $50 | $39 | $45.666 | $42.64 | 7.1% |
| 2022-05-16 | 7 | $50 | $27 | $43 | $42.64 | 0.84% |
| 2022-05-24 | 7 | $50 | $20 | $42 | $42.64 | -1.5% |
| 2022-08-02 | 8 | $50 | $20 | $39.285 | $42.64 | -7.87% |
| 2022-08-03 | 8 | $50 | $20 | $40.125 | $42.64 | -5.9% |
| 2022-08-09 | 8 | $54 | $20 | $40.625 | $42.64 | -4.73% |
| 2022-08-22 | 8 | $54 | $20 | $42 | $42.64 | -1.5% |
| 2022-08-23 | 8 | $54 | $20 | $42.625 | $42.64 | -0.04% |
| 2022-09-12 | 9 | $52 | $20 | $42.375 | $42.64 | -0.62% |
| 2022-09-21 | 9 | $52 | $28 | $43.375 | $42.64 | 1.72% |
| 2022-09-26 | 10 | $52 | $28 | $42.778 | $42.64 | 0.32% |
| 2022-09-29 | 11 | $52 | $28 | $42.6 | $42.64 | -0.09% |
| 2022-10-12 | 10 | $52 | $28 | $42.6 | $42.64 | -0.09% |
| 2022-10-20 | 11 | $52 | $28 | $42.272 | $42.64 | -0.86% |
| 2022-11-01 | 12 | $52 | $28 | $42.083 | $42.64 | -1.31% |
| 2022-11-09 | 12 | $52 | $28 | $41.916 | $42.64 | -1.7% |
| 2022-11-14 | 12 | $52 | $28 | $41.583 | $42.64 | -2.48% |
| 2022-12-19 | 13 | $52 | $28 | $40.833 | $42.64 | -4.24% |
| 2023-01-26 | 13 | $52 | $28 | $41.25 | $42.64 | -3.26% |
| 2023-02-24 | 13 | $52 | $28 | $39.416 | $42.64 | -7.56% |
| 2023-03-09 | 13 | $52 | $26 | $39.083 | $42.64 | -8.34% |
| 2023-03-17 | 13 | $52 | $26 | $38.166 | $42.64 | -10.49% |
| 2023-04-05 | 12 | $52 | $26 | $37.454 | $42.64 | -12.16% |
| 2023-05-03 | 13 | $52 | $26 | $37.454 | $42.64 | -12.16% |
| 2023-05-04 | 13 | $46.001 | $26 | $36.818 | $42.64 | -13.65% |
| 2023-05-08 | 13 | $46.001 | $28 | $37.091 | $42.64 | -13.01% |
| 2023-05-11 | 13 | $46.001 | $28 | $37.272 | $42.64 | -12.59% |
| 2023-06-06 | 13 | $46.001 | $29 | $37.454 | $42.64 | -12.16% |
| 2023-07-11 | 13 | $46.001 | $22 | $36.818 | $42.64 | -13.65% |
| 2023-08-02 | 13 | $45 | $22 | $36.1 | $42.64 | -15.34% |
| 2023-08-03 | 13 | $44 | $22 | $34.9 | $42.64 | -18.15% |
| 2023-08-07 | 12 | $42 | $24 | $34.555 | $42.64 | -18.96% |
| 2023-09-28 | 13 | $42 | $24 | $34.4 | $42.64 | -19.32% |
| 2023-11-02 | 12 | $42 | $24 | $33.555 | $42.64 | -21.31% |
| 2023-11-17 | 12 | $42 | $24 | $34.2 | $42.64 | -19.79% |
| 2023-11-20 | 13 | $42 | $24 | $33.363 | $42.64 | -21.76% |
| 2023-12-08 | 12 | $45 | $24 | $36.09 | $42.64 | -15.36% |
| 2023-12-15 | 12 | $45 | $24 | $36.181 | $42.64 | -15.15% |
| 2023-12-22 | 12 | $45 | $24 | $36.636 | $42.64 | -14.08% |
The Trend in the Analyst Price Target
Over the past 38 months, CERE's average price target has gone up $19.64.
Over the past 47 weeks, CERE's average upside potential has been 36.92%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-24 | 13 | 52.000 | 28 | 41.250 | 32.61 | 26.49% |
| 2023-03-17 | 13 | 52.000 | 26 | 37.454 | 23.39 | 60.13% |
| 2023-05-08 | 13 | 46.001 | 28 | 37.091 | 32.74 | 13.29% |
| 2023-06-06 | 14 | 46.001 | 22 | 36.818 | 33.05 | 11.4% |
| 2023-11-02 | 12 | 42.000 | 24 | 33.555 | 24.88 | 34.87% |
CERE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.67 | 2 | 0 | 10 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
CERE's average broker recommendation rating worsened by 1.5 over the prior 36 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CERE has a higher upside potential (average analyst target price relative to current price) than 1139.8% of all US stocks.
- CERE has a greater number of analysts covering the stock than 4014.97% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, CEREVEL THERAPEUTICS HOLDINGS INC's variance in analysts' estimates is lower than -3453.03% of them.
- CEREVEL THERAPEUTICS HOLDINGS INC's average analyst price target is greater than 3554.8% of Pharmaceutical Products stocks.
Stocks similar to CEREVEL THERAPEUTICS HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NUVB, NKTX, and ALXO.
View All Top Stocks by Price Target
Is CERE a Buy, Hold or Sell? See the POWR Ratings now!